IBL Healthcare reports lower profit and EPS for the quarter ended 30-09-2026
Financial ResultIBL Healthcare Limited announced unaudited financial results for the quarter ended 30-09-2026. Revenue was broadly flat year on year, but gross profit, operating profit, profit after taxation and EPS declined. No cash dividend, bonus shares or rights shares were recommended.
Payout
- No cash dividend
Key Findings
- Revenue was Rs. 1,121.185 million, broadly unchanged year on year.
- Profit from operations declined to Rs. 92.652 million from Rs. 132.322 million.
- Profit after taxation fell to Rs. 64.050 million from Rs. 69.688 million; EPS decreased to Rs. 0.65 from Rs. 0.71.
- The Board recommended no cash dividend, bonus shares or rights shares.
Financial Performance
| Metric | PreviousQuarter ended September 30, 2025 | CurrentQuarter ended September 30, 2026 | Change |
|---|---|---|---|
| Revenue from contract with customers | PKR 1.12B | PKR 1.12B | 0% |
| Gross Profit | PKR 400.09M | PKR 391.85M | -2.1% |
| Profit from operations | PKR 132.32M | PKR 92.65M | -30% |
| Profit after taxation | PKR 69.69M | PKR 64.05M | -8.1% |
| Earnings per share - basic and diluted | 0.71 | 0.65 | -8.5% |
| Finance cost | PKR 9.2M | PKR 1M | -89.1% |
| Cash and bank balances | PKR 727.18M | PKR 191.36M | -73.7% |
⚡
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.